“Air Shield” Protective Gear

The Design-Tech Lab at Technion and Rambam Health Care Campus have developed an innovative device for medical staff’s masks, that continuously blows air on their faces, improving protection against infection while eliminating fogging and overheating. Prof. Ezri Tarazi, Chair of the Industrial Design Program and…

Read more

New Rapid Test for Detecting COVID-19

Scientists at Technion’s Rappaport Faculty of Medicine have modified a coronavirus rapid and simple detection method that does not require special lab equipment, only hot water, and reagents Prof. Naama Geva-Zatorsky from the Ruth and Bruce Rappaport Faculty of Medicine at Technion-Israel Institute of Technology,…

Read more
https://www.mycause.com.au/page/226756/the-technion-covid19-emergency-research-fund

Covid-19 Priority Projects

As countries worldwide take unprecedented steps to protect their populations from the Corona-virus, an equally urgent race against time involves researchers working to halt the outbreak. At the Technion, over twenty research and development teams are aggressively seeking solutions in areas that include rapid diagnostic…

Read more

Breath Test for Corona

Prof. Hossam Haick and his team have shifted their focus to applying nanosensor technology to facilitate rapid and remote screening for COVID-19. These intelligent sensory systems can be used to diagnose Corona, and future epidemics. The group’s research focuses on breath testing using nano-sensors and…

Read more

Breakthrough in Slaughter-Free Steak Production

Researchers from the Technion and from Aleph Farms have achieved a breakthrough in the production of cultivated meat grown outside an animal’s body. As reported in the journal Nature Food, soy protein―which is readily available and economically efficient―can be used as scaffolds for growing bovine…

Read more

Pooling Method for Accelerated Testing of COVID-19

Technion and Rambam Health Care Campus scientists present a novel method for testing more than 60 patients simultaneously Researchers at Technion – Israel Institute of Technology and Rambam Health Care Campus have successfully tested a method that will dramatically increase the current COVID-19 testing capacity…

Read more

Innovative 3D–design saves coral reefs

World’s first bioplastic and ceramic tile coral reef, developed by Prof. Ezri Tarazi, head of the Industrial Design Graduate Program at Technion, in collaboration with marine biologists at Ben-Gurion University. The Technion-BGU team are developing state-of-the-art design technologies to rehabilitate the underwater world. Watch video.

Read more
Assistant Professor Shai Shen-Orr

Accelerating New Medical Therapies

Found In Translation: Algorithm Could Speed Up Development of New Medical Therapies In findings published today in Nature Methods, Israeli and American researchers reported on a revolutionary, big data-driven, machine learning algorithm designed to predict results of human gene expression based on preliminary results of…

Read more
A. Prof Ester Segal

Fundraising – Pancreatic Cancer Research

Thanks to generous gifts from our community, we’ve raised over $8,000 to support the important Pancreatic Cancer research – make a gift today and continue supporting this important cause. The Problem Cancer is Australia’s leading cause of burden of disease. Pancreatic Cancer is considered among the deadliest…

Read more

Can positive emotions shrink cancer tumors?

Artificially activating the “reward system” in the brains of mice with two types of cancer led to a dramatic reduction in the size of their tumors, according to authors of a study conducted at the Technion-Israel Institute of Technology. “The relationship between a person’s emotional…

Read more
pediatric-tumor-reasearch

Delivering Anti-Cancer Drugs to Pediatric Tumors

Spotlight on a Technion Australia priority project In most of the Western World, cancer is the primary cause of death in  children over the age of one year. Existing treatments for adult cancer patients are not particularly effective for children. This is because chemotherapeutic drugs…

Read more